Enlicitide (chloride)
Enlicitide chloride is an orally active inhibitor for PCSK9 that blocks the interaction between LPL receptor and PSCK9, with an IC50 of 2.5 nM. Enlicitide chloride can be used in the study of cardiovascular diseases such as atherosclerosis, hypercholesterolemia, coronary heart disease, metabolic syndrome, acute coronary syndrome or related cardiovascular and cardiometabolic disorders[1][2][3].
Product Specifications
CAS Number
2407527-16-4
Product Name Alternative
MK-0616 (chloride)
UNSPSC
12352209
Target
PCSK9
Type
Peptides
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/enlicitide-chloride.html
Purity
99.63
Solubility
DMSO : 1 mg/mL (ultrasonic; warming)
Smiles
Molecular Formula
C82H110ClFN14O15
Molecular Weight
1586.29
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Lentiviral mouse Znhit1 shRNA (UAS) - Lentiviral mouse Znhit1 shRNA (UAS, iRFP) (25)
Rabbit anti-Calcium Sensing Receptor Antibody
Rabbit anti-Calcium Sensing Receptor Antibody
